BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20110631)

  • 1. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
    Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
    J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
    Silpa-archa N; Wongpraparut C
    J Med Assoc Thai; 2011 Sep; 94(9):1154-7. PubMed ID: 21970208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
    Saunier J; Debarbieux S; Jullien D; Garnier L; Dalle S; Thomas L
    Dermatology; 2015; 230(2):97-100. PubMed ID: 25471551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
    Kazinski K; Joyce KM; Hodson D
    J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.
    Wen P; Liu C; Wang T; Jiang X; Wang P; Wang S
    Front Immunol; 2024; 15():1338285. PubMed ID: 38464535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau.
    Weisshaar E; Diepgen TL
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):489-92. PubMed ID: 17537042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate.
    Sotiriadis D; Patsatsi A; Sotiriou E; Sotiriou E; Papagaryfallou I; Chrysomallis F
    J Dermatolog Treat; 2007; 18(5):315-8. PubMed ID: 17852633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).
    Thielen AM; Barde C; Marazza G; Saurat JH
    Dermatology; 2008; 217(2):137-9. PubMed ID: 18503258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
    Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
    J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.
    Chu DH; Van Voorhees AS; Rosenbach M
    Arch Dermatol; 2011 Oct; 147(10):1228-30. PubMed ID: 22006150
    [No Abstract]   [Full Text] [Related]  

  • 12. Etanercept responsive acrodermatitis continua of Hallopeau: is a pattern developing?
    Bonish B; Rashid RM; Swan J
    J Drugs Dermatol; 2006 Oct; 5(9):903-4. PubMed ID: 17039659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
    Nikkels AF; Piérard GE
    J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.
    Tobin AM; Kirby B
    Br J Dermatol; 2005 Aug; 153(2):445-6. PubMed ID: 16086767
    [No Abstract]   [Full Text] [Related]  

  • 16. Onychomycosis in patients of nail psoriasis on biologic therapy: a randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab.
    Al-Mutairi N; Nour T; Al-Rqobah D
    Expert Opin Biol Ther; 2013 May; 13(5):625-9. PubMed ID: 23527597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report.
    Crowley EL; Maliyar K; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    SAGE Open Med Case Rep; 2019; 7():2050313X19829620. PubMed ID: 30800311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrodermatitis continua of Hallopeau response to optimized biological therapy.
    Adas A; Dadban A; Arnault JP; Chaby G; Lok C
    Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of systemic therapies for moderate to severe psoriasis.
    Sizto S; Bansback N; Feldman SR; Willian MK; Anis AH
    Br J Dermatol; 2009 Jun; 160(6):1264-72. PubMed ID: 19120346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acrodermatitis continua resistant to etanercept: therapeutic challenge and unfortunate outcome.
    Gokdemir G; Kutlu S; Köşlü A
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):345-7. PubMed ID: 18554224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.